treatment outcomes among a cohort failing macrolide resistance-guided treatment across three London sexual health clinics.

Objective: British guidelines advise treatment of () infection using the results of macrolide resistance-associated mutation (MRAM) assays. Limited data informs management when patients fail MRAM-guided treatment. This study evaluates current management strategies employed for cases of infection with MRAM-guided treatment failure.